Search by Drug Name or NDC
NDC 64764-0337-60 KAZANO 12.5; 1000 mg/1; mg/1 Details
KAZANO 12.5; 1000 mg/1; mg/1
KAZANO is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE.
Product Information
| NDC | 64764-0337 |
|---|---|
| Product ID | 64764-337_7e03a27c-c802-48a0-801c-785f55f1df36 |
| Associated GPIs | 27992502100330 |
| GCN Sequence Number | 070527 |
| GCN Sequence Number Description | alogliptin benz/metformin HCl TABLET 12.5-1000 ORAL |
| HIC3 | C4F |
| HIC3 Description | ANTIHYPERGLYCEMIC,DPP-4 INHIBITOR-BIGUANIDE COMBS. |
| GCN | 34088 |
| HICL Sequence Number | 039970 |
| HICL Sequence Number Description | ALOGLIPTIN BENZOATE/METFORMIN HCL |
| Brand/Generic | Brand |
| Proprietary Name | KAZANO |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | alogliptin and metformin hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 12.5; 1000 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE |
| Labeler Name | Takeda Pharmaceuticals America, Inc. |
| Pharmaceutical Class | Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA203414 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 64764-0337-60 (64764033760)
| NDC Package Code | 64764-337-60 |
|---|---|
| Billing NDC | 64764033760 |
| Package | 60 TABLET, FILM COATED in 1 BOTTLE (64764-337-60) |
| Marketing Start Date | 2013-01-25 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 6.57496 |
| Pricing Unit | EA |
| Effective Date | 2024-01-17 |
| NDC Description | KAZANO 12.5-1,000 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis